Smith, Moore & Co. Pfizer Inc Transaction History

Smith, Moore & Co.

$935 Million
Q1 2024

A detailed history of Smith, Moore & Co. transactions in Pfizer Inc stock. As of the latest transaction made, Smith, Moore & Co. holds 61,312 shares of PFE stock, worth $1.71 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

61,312

Previous 56,041 9.41%

Holding current value

$1.71 Million

Previous $1.61 Million 5.46%

% of portfolio

0.18%

Previous 0.19%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$25.89 - $29.73 $136,466 - $156,706	5,271 Added 9.41%	61,312 $1.7 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $193,962 - $251,936	-7,423 Reduced 11.7%	56,041 $1.61 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $28,367 - $33,158	-884 Reduced 1.37%	63,464 $2.11 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $62,198 - $71,962	1,722 Added 2.75%	64,348 $2.36 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $24,736 - $32,203	-628 Reduced 0.99%	62,626 $2.56 Million

Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $50,517 - $65,945	-1,210 Reduced 1.88%	63,254 $3.24 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $117,626 - $143,592	2,688 Added 4.35%	64,464 $2.82 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $49,600 - $58,811	-1,066 Reduced 1.7%	61,776 $3.24 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $103,440 - $128,176	2,261 Added 3.73%	62,842 $3.25 Million
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $12,891 - $19,110	312 Added 0.52%	60,581 $3.58 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $196 - $252	-5 Reduced 0.01%	60,269 $2.59 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $239,052 - $270,806	6,657 Added 12.42%	60,274 $2.36 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $189,821 - $214,080	5,668 Added 11.82%	53,617 $1.94 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $20,617 - $26,216	-616 Reduced 1.27%	47,949 $1.77 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $76,517 - $89,772	2,410 Added 5.22%	48,565 $1.78 Million
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $51,746 - $62,775	-1,718 Reduced 3.59%	46,155 $1.51 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $73,981 - $105,702	2,737 Added 6.06%	47,873 $1.56 Million
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $110,578 - $125,492	-3,359 Reduced 6.93%	45,136 $1.77 Million
Q3 2019 Nov 07, 2019	BUY	$32.49 - $42.13 $81,842 - $106,125	2,519 Added 5.48%	48,495 $1.74 Million
Q2 2019 Aug 15, 2019	BUY	$36.98 - $41.52 $6,915 - $7,764	187 Added 0.41%	45,976 $1.99 Million
Q1 2019 May 07, 2019	SELL	$37.5 - $41.2 $135,112 - $148,443	-3,603 Reduced 7.29%	45,789 $1.95 Million
Q4 2018 Feb 15, 2019	SELL	$38.47 - $43.86 $334,458 - $381,318	-8,694 Reduced 14.97%	49,392 $2.16 Million
Q3 2018 Nov 15, 2018	BUY	$34.47 - $41.81 $75,523 - $91,605	2,191 Added 3.92%	58,086 $2.56 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $81,889 - $87,302	2,483 Added 4.65%	55,895 $2.03 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $58,554 - $67,931	1,835 Added 3.56%	53,412 $1.9 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $128,815 - $136,678	3,873 Added 8.12%	51,577 $1.87 Million
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $1.48 Million - $1.63 Million	47,704	47,704 $1.7 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Moore & Co., based on Form 13F filings with the SEC.

News

Stay updated on Smith, Moore & Co. with notifications on news.

Account